Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Tables)

v3.21.2
Stockholders' Equity (Tables)
 12 Months Ended
Jun. 30, 2021
Equity [Abstract]  
Schedule of sales through equity offering program
Three months ended     Avg price
per share		     Number of
Shares		     Gross
Proceeds
(in millions)		     Offering
Expenses
(in millions)		     Net
Proceeds
(in millions)		  
September 30, 2020     $ 8.09       416,221     $ 3.4     $ 0.1     $ 3.3  
December 31, 2020     $ 8.93       2,296,023     $ 20.5     $ 0.4     $ 20.1  
March 31, 2021     $ 14.99       2,082,148     $ 31.2     $ 0.5     $ 30.7  
June 30, 2021     $ 10.01       762,197     $ 7.6     $ 0.1     $ 7.5  
Total     $ 11.28       5,556,589     $ 62.7     $ 1.1     $ 61.6  

 
Schedule of Black-Scholes option pricing model with weighted average assumptions
    June 30,
2021		     June 30,
2020		  
Exercise price   $7.72 – $17.61     $4.71 – $8.15  
Expected term (years)   4.00 – 5.00     4.75 – 5.00  
Risk-free interest rate   0.25 – 0.78%     0.32 – 1.74%  
Volatility   67 – 68%     65 – 69%  
Dividend yield   0%   0%
Weighted Average Grant Date Fair Value of Options granted during the period   $5.09     $4.31  

 
Schedule of option activity
    Options     Weighted-
Average
Exercise
Price		     Weighted-
Average
Remaining
Contractual
Term (in years)		     Aggregate
Intrinsic
Value
 (in thousands)		  
Outstanding – June 30, 2020     2,294,415       5.84                  
Granted     520,604       9.32                  
Exercised     (219,192 )     6.10                  
Forfeited/Cancelled     (98,250 )     7.07                  
Outstanding – June 30, 2021     2,497,577       6.49       4.54       10,911  
Exercisable – June 30, 2021     1,294,098       5.44       3.87       6,826  

 
Schedule of unrecognized stock-based compensation expense and weighted-average years
    As of June 30, 2021  
   

Unrecognized stock-

based
compensation

    Weighted-
average
years
to be recognized		  
Options   $ 2,502       2.18  
Restricted stock awards/units   $ 8,081       2.21  

 
Schedule of stock-based compensation expense
    2021     2020  
Research and Development   $ 4,037     $ 3,454  
General and Administrative     4,155       3,280  
Total   $ 8,192     $ 6,734  

 
Schedule of unvested restricted stock awards (“RSAs”) and restricted stock unit awards (“RSUs”)
    Number of
RSAs/RSUs		     Weighted
Average
Fair Value
per
Share/Unit		  
Outstanding - June 30, 2020     1,689,836     $ 7.07  
Granted     856,961       9.77  
Vested     (707,189 )     6.87  
Forfeited/Cancelled/Repurchased     (92,000 )     7.49  
Outstanding – June 30, 2021     1,747,608       8.45